The latest studies demonstrated that GAS5 usually functions as a tumour suppressor to control apoptosis of various cancer cells, including breast cancer, prostate cancer, renal cell carcinoma, and ovarian cancer [12, 37–39]. This evidence concerns the gene GAS5 and prostate cancer.